Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals

Hepatitis C virus pharmacogenomics in Latin American populations: implications in the era of direct-acting antivirals

Julieta Trinks,1,2 Mariela Caputo,2,3 María L Hulaniuk,1 Daniel Corach,2,3 Diego Flichman2,4 1Basic Science and Experimental Medicine Institute (ICBME), University Institute of the Italian Hospital of Buenos Aires, 2Scientific and Technological National Research Council (CONICET), 3Servic...

Full description

Bibliographic Details
Main Authors: Trinks J, Caputo M, Hulaniuk ML, Corach D, Flichman D
Format: Article
Language:English
Published: Dove Medical Press 2017-03-01
Series:Pharmacogenomics and Personalized Medicine
Subjects:
Hepatitis C virus
pharmacogenomics
PEG-IFN/RBV
DAAs
Latin America
Online Access:https://www.dovepress.com/hepatitis-c-virus-pharmacogenomics-in-latin-american-populations-impli-peer-reviewed-article-PGPM

Internet

https://www.dovepress.com/hepatitis-c-virus-pharmacogenomics-in-latin-american-populations-impli-peer-reviewed-article-PGPM

Similar Items